Nate Larson

2.6k total citations · 1 hit paper
10 papers, 878 citations indexed

About

Nate Larson is a scholar working on Biomaterials, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Nate Larson has authored 10 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomaterials, 5 papers in Molecular Biology and 5 papers in Biomedical Engineering. Recurrent topics in Nate Larson's work include Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (4 papers) and RNA Interference and Gene Delivery (3 papers). Nate Larson is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (4 papers) and RNA Interference and Gene Delivery (3 papers). Nate Larson collaborates with scholars based in United States, India and Germany. Nate Larson's co-authors include Hamidreza Ghandehari, Abhijit Ray, Adam J. Gormley, Ryan Robinson, Hillevi Bauer, Khaled Greish, Shraddha Sadekar, Alexander Malugin, Daniel B. Pike and D.L. Cheney and has published in prestigious journals such as Chemistry of Materials, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Nate Larson

10 papers receiving 863 citations

Hit Papers

Polymeric Conjugates for Drug Delivery 2012 2026 2016 2021 2012 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nate Larson United States 9 523 391 320 157 126 10 878
Abby M. Gonik United States 5 766 1.5× 511 1.3× 489 1.5× 137 0.9× 157 1.2× 6 1.2k
Edward Van Kirk United States 8 655 1.3× 442 1.1× 473 1.5× 219 1.4× 161 1.3× 8 1.1k
Catherine Passirani France 18 565 1.1× 385 1.0× 432 1.4× 196 1.2× 70 0.6× 20 1.1k
Chris Oerlemans Netherlands 9 626 1.2× 418 1.1× 260 0.8× 206 1.3× 95 0.8× 11 946
Anjan Nan United States 19 618 1.2× 384 1.0× 495 1.5× 176 1.1× 107 0.8× 25 1.3k
Zachary H. Houston Australia 21 436 0.8× 314 0.8× 363 1.1× 302 1.9× 127 1.0× 45 1.1k
Manju Kanamala New Zealand 9 653 1.2× 527 1.3× 419 1.3× 114 0.7× 83 0.7× 12 1.1k
Stefanie Wedepohl Germany 21 509 1.0× 497 1.3× 426 1.3× 224 1.4× 152 1.2× 52 1.3k
David A. Eavarone United States 7 518 1.0× 420 1.1× 470 1.5× 86 0.5× 56 0.4× 10 988
Changying Shi United States 17 475 0.9× 302 0.8× 376 1.2× 219 1.4× 189 1.5× 37 1.0k

Countries citing papers authored by Nate Larson

Since Specialization
Citations

This map shows the geographic impact of Nate Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nate Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nate Larson more than expected).

Fields of papers citing papers by Nate Larson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nate Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nate Larson. The network helps show where Nate Larson may publish in the future.

Co-authorship network of co-authors of Nate Larson

This figure shows the co-authorship network connecting the top 25 collaborators of Nate Larson. A scholar is included among the top collaborators of Nate Larson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nate Larson. Nate Larson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Larson, Nate, et al.. (2014). In Vitro Synergistic Action of Geldanamycin- and Docetaxel-Containing HPMA Copolymer-RGDfK Conjugates Against Ovarian Cancer. Macromolecular Bioscience. 14(12). 1735–1747. 7 indexed citations
2.
Larson, Nate, et al.. (2013). Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment. International Journal of Pharmaceutics. 454(1). 435–443. 47 indexed citations
4.
Gormley, Adam J., Nate Larson, Afsheen Banisadr, et al.. (2012). Plasmonic photothermal therapy increases the tumor mass penetration of HPMA copolymers. Journal of Controlled Release. 166(2). 130–138. 57 indexed citations
5.
Gormley, Adam J., Nate Larson, Shraddha Sadekar, et al.. (2012). Guided delivery of polymer therapeutics using plasmonic photothermal therapy. Nano Today. 7(3). 158–167. 104 indexed citations
6.
Larson, Nate & Hamidreza Ghandehari. (2012). Polymeric Conjugates for Drug Delivery. Chemistry of Materials. 24(5). 840–853. 465 indexed citations breakdown →
7.
Ray, Abhijit, Nate Larson, Daniel B. Pike, et al.. (2011). Comparison of Active and Passive Targeting of Docetaxel for Prostate Cancer Therapy by HPMA Copolymer–RGDfK Conjugates. Molecular Pharmaceutics. 8(4). 1090–1099. 48 indexed citations
8.
Larson, Nate, Khaled Greish, Hillevi Bauer, Hiroshi Maeda, & Hamidreza Ghandehari. (2011). Synthesis and evaluation of poly(styrene-co-maleic acid) micellar nanocarriers for the delivery of tanespimycin. International Journal of Pharmaceutics. 420(1). 111–117. 38 indexed citations
9.
Greish, Khaled, Abhijit Ray, Hillevi Bauer, et al.. (2011). Anticancer and antiangiogenic activity of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer therapy. Journal of Controlled Release. 151(3). 263–270. 37 indexed citations
10.
Larson, Nate, Abhijit Ray, Alexander Malugin, Daniel B. Pike, & Hamidreza Ghandehari. (2010). HPMA Copolymer-Aminohexylgeldanamycin Conjugates Targeting Cell Surface Expressed GRP78 in Prostate Cancer. Pharmaceutical Research. 27(12). 2683–2693. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026